DMP1 protein inhibits angiogenesis, could lead to new treatments against cancer and other diseases
Wednesday, January 26, 2011 - 13:37
in Health & Medicine
Researchers in Belgium have demonstrated that the DMP1 protein has previously unsuspected anti-angiogenic activities which could be used for the development of new treatments against cancer, but also against diseases in which angiogenesis (the formation of new blood vessels) plays a major role, such as psoriasis, rheumatoid arthritis or diabetic retinopathy.